Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria

Multiple Sclerosis

Volumn 22, Issue 10, 2016, Pages 1371-1375

  Uzawa, Akiyuki ^a   Mori, Masahiro ^a   Uchida, Tomohiko ^a   Masuda, Hiroki ^a   Ohtani, Ryohei ^a   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Diagnostic criteria; glial fibrillary acidic protein; interleukin 6; neuromyelitis optica; seronegative

Indexed keywords

AQUAPORIN 4 ANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 6; METHYLPREDNISOLONE; MYELIN BASIC PROTEIN; OLIGOCLONAL BAND; PREDNISOLONE; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY; IL6 PROTEIN, HUMAN; GADOLINIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC CRITERIA; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROMYELITIS OPTICA SPECTRUM DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; BRAIN; CEREBROSPINAL FLUID; DIAGNOSTIC IMAGING; IMMUNOLOGY; MYELITIS; RETROSPECTIVE STUDY; SPINAL CORD; APHERESIS; AREA POSTREMA; ATAXIC GAIT; BRAIN STEM; BULBAR PARALYSIS; CASE REPORT; CENTRAL CORD SYNDROME; CEREBELLUM; CEREBELLUM CORTEX; CERVICAL SPINAL CORD INJURY; COGNITIVE DEFECT; CONSCIOUSNESS; CONSCIOUSNESS DISORDER; DIPLOPIA; HEARING IMPAIRMENT; HEMIPARESIS; HICCUP; HOMONYMOUS HEMIANOPIA; HYPOTHALAMUS; MAJOR CLINICAL STUDY; MIDDLE CEREBELLAR PEDUNCLE; NAUSEA; NYSTAGMUS; PONS; RESEARCH DIAGNOSTIC CRITERIA; SENSORY DYSFUNCTION; SERODIAGNOSIS; WEAKNESS;

ADULT; AQUAPORIN 4; AUTOANTIBODIES; BRAIN; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INTERLEUKIN-6; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELITIS, TRANSVERSE; NEUROMYELITIS OPTICA; OLIGOCLONAL BANDS; RETROSPECTIVE STUDIES; SPINAL CORD;

EID: 84986557940     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515615954     Document Type: Article

References (9)

1. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
2. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85: 177-189.
3. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005; 58: 840-846.
4. Hayakawa S, Mori M, Okuta A, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 2008; 196: 181-187.
5. Uzawa A, Mori M, Sawai S, et al. Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks. Clin Chim Acta 2013; 421: 181-183.
6. Ito S, Mori M, Makino T, et al. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009; 66: 425-428.
7. Uzawa A, Mori M, Arai K, et al. Cytokine and chemokine profiles in neuromyelitis optica: Significance of interleukin-6. Mult Scler 2010; 16: 1443-1452.
8. Takano R, Misu T, Takahashi T, et al. Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study. Neurology 2010; 75: 208-216.
9. Ikeda K, Kiyota N, Kuroda H, et al. Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody. Mult Scler 2015; 21: 656-659.